Utilisation of macrolides and the development of Streptococcus pyogenes resistance to erythromycin
- 41 Downloads
Objectives: The aim of the study was to evaluate the relationship between the development of the resistance of Streptococcus pyogenes strains to erythromycin and the utilisation of macrolides in the Olomouc region, Czech Republic.
Method: During the period 1997–2001, data for utilisation of macrolides was obtained from the database of regional General Health Insurance Company and expressed in defined daily doses per 1000 patients per day. S. pyogenes strains were isolated from community patients suffering from acute bacterial tonsillitis. Their susceptibility to antibiotics was assessed by the disk diffusion method.
Result: Utilisation of macrolides increased by 13% in the period 1997–2001; their utilisation represented 11.40% of total antibiotic prescription in 1997 and 15.48% in 2001. Occurrence of erythromycin-resistant S. pyogenes strains increased significantly from 14% in 1997 to 32% in the year 2001 (P < 0.01). In 2000, macrolides consumption decreased non-significantly, but with no concomitant decrease in erythromycin-resistant S. pyogenes strains occurrence. Absolute susceptibility of S. pyogenes, the most important bacterial pathogen in community-acquired bacterial tonsillitis, to penicillin contrasts with increasing macrolide resistance.
Conclusions: The study documents the influence of increased utilisation of macrolides on bacterial resistance. Penicillin should be a first choice antibiotic in acute bacterial tonsillitis; macrolides should only be reserved for patients allergic to penicillins.
KeywordsATC-DDD system Antibiotics Czech Republic Drug resistance Drug use Macrolides Streptococcus pyogenes
Unable to display preview. Download preview PDF.
- 2.Gerber, MA. 1995Antibiotic resistance in group A streptococciPediatr Clin N Am199553951Google Scholar
- 3.Hyder, SL, Streitfeld, MM. 1973Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes Antimicrob AgentsChemother.432731Google Scholar
- 10.Pérez-Trallero, E, Fernández-Mazarrasa, C, García-Rey, C, Bouza, E, Aguilar, L, Garcia-de-Lomas, J., et al. 2001Antimicrobial suceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: result of a 1-year (1998-1999) multicenter surveillance study in SpainAntimicrob Agents Chemother.45333440CrossRefPubMedGoogle Scholar
- 13.Cornaglia, G, Ligozzi, M, Mazzariol, A, Valentini, M, Orefici, G., Fontana, R 1996Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy 1993–1995Emerging Dis.233942Google Scholar
- 16.Anatomical therapeutic chemical (ATC) index (including defined daily doses (DDDs) for plain substances). WHO collaboration centre for drugs statistics methodology, Oslo, 2001Google Scholar
- 17.National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Sixth informational supplement. Nat Comm Clin Lab Standards, Villanova, PA, 1995Google Scholar
- 20.Urbášková P and Working Group Surveillance of the antibiotic resistance of the most common bacterial pathogens causing respiratory tract infections in the Czech Republic. Remedia 2000; 10: 195-203Google Scholar